Navigation Links
EntreMed Reports Second Quarter 2008 Financial Results
Date:8/6/2008

EntreMed to Conduct Update Call on Tuesday, August 12, 2008

ROCKVILLE, Md., Aug. 6 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today reported financial results for the three and six-month periods ending June 30, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

The Company reported a net loss for the second quarter of 2008 of ($9.6 million), or ($0.11) per share. This compares with a net loss of ($7.9 million), or ($0.10) per share, for the same period last year. For the first six months of 2008 the reported net loss was ($17.9 million), or ($0.22) per share as compared to ($15.6 million), or ($0.19) per share for 2007. The 2008 net loss for the three and six-month periods include a non-cash charge of $2.0 million, which represents a purchase price adjustment milestone triggered by the dosing of the first patient in a clinical trial for ENMD-2076, the lead molecule in our Aurora kinase program acquired from Miikana Therapeutics in January 2006.

The Company did not report any revenues for the first six months of 2008, although the Company believes that it will record royalty revenues in excess of $7 million on sales of Thalomid(R) by Celgene in the third and fourth quarters of 2008. As of June 30, 2008, EntreMed had cash and short-term investments of approximately $36 million.

Dane Saglio, EntreMed Chief Financial Officer, commented on the second quarter results, "During the second quarter of 2008, we recorded a $2.0 million non-cash charge resulting from the Company's dec
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. EntreMed Appoints Thomas H. Bliss as Senior Vice President of Corporate and Business Development
2. Dana-Farber Cancer Institute Commences Phase 1 Trial With EntreMeds Selective Kinase Inhibitor
3. EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
4. EntreMeds Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
5. EntreMed Receives Nasdaq Deficiency Notice
6. EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
7. EntreMed Announces 2008 Corporate and Clinical Program Priorities
8. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
9. EntreMed to Present at BIO CEO and Investor Conference
10. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
11. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 Just released this ... executive coach and author Barbara Roche: “Commit to Confidence: ... , Filled with helpful tips and quotes from the fields ... leaders, and tangible exercises that readers can do on their ... to achieve their personal and professional goals. , ...
(Date:5/22/2013)... Washington, NY (PRWEB) May 22, 2013 ... comprehensive line of accessories for the mobile lifestyle, announces ... charge, sync, protect, and manage multiple iPad devices efficiently. ... award and the 2012 Good Design award, MultiCharger-X is ... the iPad, wherever it is deployed. , ...
(Date:5/22/2013)... , May 22, 2013   Oligomerix, Inc. ... of disease modifying therapeutics for Alzheimer,s disease (AD) ... of its Series B financing, which includes both ... that would represent approximately $2.8M in new investments ... investors supported the raise. Funding ...
(Date:5/22/2013)... NEW ORLEANS , May 22, 2013 /PRNewswire/ ... regenerative medicine, presented new data generated in collaboration with ... leading health economics consultancy) demonstrating the significant healthcare resource ... venous leg ulcers (VLU) place upon the US healthcare ... which reveal annual costs of up to $15 billion ...
Breaking Biology Technology:iLuv Now Shipping the All New MultiCharger-X 2iLuv Now Shipping the All New MultiCharger-X 3Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 2Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 3Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers 4
... returned yesterday from a week's trip to Sao Paulo, Brazil, ... America course, a group of executive MBA students (from Midwest ... Sao Paulo Business School . , ,Sao Paul ... thought were two of the largest cities of the world, ...
... - Taking more women-owned businesses to the $1 million annual ... perhaps none more important than information technology. , ,That was ... Wisconsin Make Mine a Million program, where women-owned ... extent in their quest to reach the $1 million mark. ...
... who wonder where their future technologists will come ... school students soon will graduate from an intensive ... of Wisconsin-Madison's Information Technology Academy . , ... hands-on training and access to technology for talented ...
Cached Biology Technology:Brazilian bio-industry should impress American investors 2Brazilian bio-industry should impress American investors 3Brazilian bio-industry should impress American investors 4Brazilian bio-industry should impress American investors 5Brazilian bio-industry should impress American investors 6Learning from the big boys: With technology, women urged to go gradual 2Learning from the big boys: With technology, women urged to go gradual 3
(Date:5/21/2013)... Chicago College of Medicine will study gender differences in how ... source -- and how changes in fat metabolism play a ... grant from the National Heart, Lung and Blood Institute. , ... energy. These changes may play a major role in the ... women, says E. Douglas Lewandowski, director of the UIC Center ...
(Date:5/21/2013)... action in cells in precise detail like never before. ... wrong in diabetes. , The breakthrough study, conducted ... Garvan Institute of Medical Research, is now published in ... Cell Metabolism . , First discovered in 1921, the ... body because it helps us lower blood sugar after ...
(Date:5/20/2013)... the effect of physical education (PE) on child weight, ... increasing the amount of time that elementary schoolchildren spent ... The study represents some of the first evidence of ... is forthcoming in the Journal of Health Economics ... can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The ...
Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3Gym class reduces probability of obesity, study finds for first time 2
... This press release is available in German . ... only have small wings compared to their body size. Scientists ... Munich, Germany, recently identified the genetic switch that regulates the ... the generation of the ultrafast super muscles," emphasizes Frank Schnorrer, ...
... knows that climate affects our water supply, but new ... water-resource managers an unprecedented level of detail on how ... in the Southeast. Researchers found that the groundwater, ... is directly influenced by the amount of precipitation that ...
... Li Qian, PhD, has won the Louis N. and ... Investigators from the American Heart Association (AHA), marking the ... Gladstone Institutes researcher has been the recipient. ... a leading and independent biomedical-research organization -- and a ...
Cached Biology News:How the fly flies 2Gladstone scientist receives American Heart Association's Katz prize for cardiovascular research 2
... Resolution - Efficiently separates ... to 1000 bp. It ... PCR fragments, small DNA ... enzyme digestion, and double-stranded ...
... Anti-PRK2 MW 140kDa ... Immunogen Peptide spanning amino acids ... Purification immunoaffinity purified Quality ... RIPA lysates from HeLa cells. ...
MarrowMAX Bone Marrow Medium...
Histone H2A Polyclonal Antibody 100 ug affinity purified rabbit polyclonal antibody. Detects ~14 kDa Histone H2A. It does not cross-react with other Histones. Reacts with human/mouse/rat. Performs w...
Biology Products: